# Plant Health Care Positive Developments with Harpin ab in sugarcane in Brazil

- Link: https://www.directorstalkinterviews.com/plant-health-care-positive-developments-with-harpin-ab-in-sugarcane-in-brazil/412761299
- Published: 2018-11-14T07:08:15+00:00
- Author: Giles Arbor

**Plant Health Care plc** (LON: PHC), a leading provider of novel patent-protected
biological products to global agriculture markets, has today provided the following
update on the launch of H2Copla (Harpin ab) in sugarcane in Brazil.

**Highlights:**

– H2Copla (Harpin ab) has been applied on some 20,000 hectares (Ha) of sugarcane
since ‘soft launch’ in February 2018

– Average yield increases in excess of 20% are driving strong demand; early adopters
plan to switch entirely to H2Copla for the next season

– Grower response to the results has been very positive

– Sales by PHC to Coplacana are expected to reach $0.8m in 2018, pointing to strong
growth in 2019

As previously announced, Brazil sugarcane, with 10 million Ha planted, is an important
target for Plant Health Care. The Company has been developing Harpin ab for use 
in this crop since 2016. Coplacana, a very large co-operative and the leading distributor
of inputs for sugarcane, was appointed as distributor to launch Harpin ab under 
the brand name H2Copla. Following a ‘soft launch’ in February 2018, Coplacana has
been carrying out extensive demonstration trials of the product; H2Copla has been
applied on some 20,000 Ha to date by various growers.

Trials conducted on behalf of the Company in 2018 showed that single applications
of a low dose (100 g per Ha), significantly increased the yield of sugarcane (10-
29%). Moreover, it is possible that the life of the crop may be extended from five
to six years, resulting in a material cost reduction for the grower, especially 
when sugar prices are low. Grower response to the results has been very positive.

Furthermore Usina Açucareira Furlan S/A (‘Furlan’), a large sugarcane producer located
in the state of São Paulo, carried out field trials in 2018, as part of the soft
launch by Coplacana, which delivered an average 23% yield increase from H2Copla 
applicatons. Furlan now plans to use H2Copla on their entire area next season.

> **Gilmar Rorigues de Morais, Agriculture Department Manager at Furlan, said** “
> We are excited about the yield increases from this year’s trials and plan to use
> H2Copla on all of our 20,000 Ha for the 2019 growing season.”
> **Chris Richards, Executive Chairman and Interim CEO of Plant Health Care plc,
> noted:** “Grower reaction to demonstration trials of H2Copla has been very positive.
> Growers have already treated some 20,000 Ha of sugarcane with the product. The
> indication that just one customer (Furlan) plans to use H2Copla on 20,000 Ha next
> year, points to significant revenue growth in 2019. Demand for Harpin ab in Brazil
> is expected to reach at least $0.8m in 2018.”

Share on:
